• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    NovaBay Pharmaceuticals, Inc. Common Stock (NY: NBY )

    0.6770 UNCHANGED
    Streaming Delayed Price Updated: 8:00 PM EST, Feb 10, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about NovaBay Pharmaceuticals, Inc. Common Stock

    < Previous 1 2 3 4 Next >
    NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders
    From NovaBay Pharmaceuticals
    Via Business Wire
    NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024
    From NovaBay Pharmaceuticals
    Via Business Wire
    Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova Brand
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NBY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NovaBay Pharmaceuticals, Inc.’s Avenova Brand and Business Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    < Previous 1 2 3 4 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.